CRDF Cardiff Oncology, Inc.
Cardiff Oncology, Inc. (CRDF) Institutional Ownership
What the institutions did with CRDF last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| Laurion Capital Management LP | 3.1M | 16.5% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.9M | 15.4% |
| Pfizer Inc | 2.4M | 12.8% |
| FRANKLIN RESOURCES INC | 1.2M | 6.4% |
| BlackRock, Inc. | 972.9K | 5.2% |
| BLAIR WILLIAM & CO/IL | 912.5K | 4.9% |
| GEODE CAPITAL MANAGEMENT, LLC | 820.1K | 4.4% |
| UBS Group AG | 638.7K | 3.4% |
| JANE STREET GROUP, LLC | 607.9K | 3.2% |
| VANGUARD FIDUCIARY TRUST CO | 410.6K | 2.2% |
| AQR CAPITAL MANAGEMENT LLC | 346.4K | 1.8% |
| STATE STREET CORP | 331.4K | 1.8% |
| HRT FINANCIAL LP | 272.8K | 1.5% |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 247.5K | 1.3% |
| MORGAN STANLEY | 246.1K | 1.3% |
| BNP PARIBAS FINANCIAL MARKETS | 228.5K | 1.2% |
| X-Square Capital, LLC | 205.7K | 1.1% |
| GSA CAPITAL PARTNERS LLP | 173.3K | 0.9% |
| MARSHALL WACE, LLP | 162.2K | 0.9% |
| Bank of New York Mellon Corp | 161.7K | 0.9% |
| NORTHERN TRUST CORP | 152.9K | 0.8% |
| Avestar Capital, LLC | 136.1K | 0.7% |
| MILLENNIUM MANAGEMENT LLC | 134.5K | 0.7% |
| Assenagon Asset Management S.A. | 134.5K | 0.7% |
| Qube Research & Technologies Ltd | 125.6K | 0.7% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| BlackRock, Inc. | Reduced | 4.0M | 972.9K | -3.0M |
| ACORN CAPITAL ADVISORS, LLC | Sold Out | 1.8M | 0 | -1.8M |
| STATE STREET CORP | Reduced | 1.2M | 331.4K | -855.6K |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 1.6M | 820.1K | -779.6K |
| JANE STREET GROUP, LLC | Increased | 40.1K | 607.9K | +567.8K |
| Laurion Capital Management LP | Increased | 2.6M | 3.1M | +451.6K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 437.2K | 72.1K | -365.2K |
| FLPUTNAM INVESTMENT MANAGEMENT CO | Reduced | 595.1K | 247.5K | -347.7K |
| NORTHERN TRUST CORP | Reduced | 493.2K | 152.9K | -340.3K |
| AQR CAPITAL MANAGEMENT LLC | Increased | 66.2K | 346.4K | +280.2K |
| HRT FINANCIAL LP | New | 0 | 272.8K | +272.8K |
| UBS Group AG | Increased | 400.6K | 638.7K | +238.1K |
| BNP PARIBAS FINANCIAL MARKETS | Increased | 13.1K | 228.5K | +215.4K |
| X-Square Capital, LLC | New | 0 | 205.7K | +205.7K |
| MORGAN STANLEY | Increased | 56.3K | 246.1K | +189.8K |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Sold Out | 164.7K | 0 | -164.7K |
| MARSHALL WACE, LLP | New | 0 | 162.2K | +162.2K |
| TWO SIGMA INVESTMENTS, LP | Reduced | 207.0K | 47.7K | -159.3K |
| XTX Topco Ltd | Reduced | 250.2K | 97.4K | -152.8K |
| Bank of New York Mellon Corp | Reduced | 303.4K | 161.7K | -141.7K |
| Nuveen, LLC | Sold Out | 130.3K | 0 | -130.3K |
| CITADEL ADVISORS LLC | Sold Out | 125.6K | 0 | -125.6K |
| Qube Research & Technologies Ltd | New | 0 | 125.6K | +125.6K |
| MILLENNIUM MANAGEMENT LLC | Increased | 23.0K | 134.5K | +111.5K |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 101.3K | 13.9K | -87.3K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.